Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study.

Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study. J Am Heart Assoc. 2020 04 21; 9(8):e015865.

View in: PubMed

subject areas

Aged
Aged
Aspirin
Aspirin
Female
Female
Florida
Florida
Hemorrhage
Hemorrhage
Humans
Humans
Lactones
Lactones
Male
Male
Middle Aged
Middle Aged
Myocardial Infarction
Myocardial Infarction
Platelet Aggregation
Platelet Aggregation
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Prasugrel Hydrochloride
Prospective Studies
Prospective Studies
Purinergic P2Y Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Pyridines
Pyridines
Thrombosis
Thrombosis
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome

authors with profiles

Usman Baber